Jim Cramer Says This Is 'One Of Those Crazy Science Stocks That In This Market Will Work Perfectly'

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he really likes Qualtrics International Inc XM as a "long-term growth play."

Analysts strongly agree, giving XM an Outperform consensus rating, according to Benzinga's analyst ratings data.

When asked about Clearfield Inc CLFD, he said, "There’s an analyst that cut numbers and the stock fell apart. That was ridiculous."

Don’t forget to check out our premarket coverage here

Cramer said CRISPR Therapeutics AG CRSP is "one of those crazy science stocks that in this market will work perfectly."

Price Action: Shares of Qualtrics were up 5.74% at $16.66, Clearfield was down 1.2% to $70.60, while CRISPR Therapeutics shares were 2% higher at $52.00 on Wednesday morning.

Now Read This: Over $5M Bet On Uber Technologies? Check Out These 4 Stocks Insiders Are Buying

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs
Posted In: Long IdeasNewsSmall CapMarketsMediaTrading IdeasCNBCJim Cramermad money Lightning Round
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!